Click here to sign in with or
Forget Password?
Learn more
share this!
14
Twit
Share
Email
May 13, 2024
This article has been reviewed according to Science X’s editorial process and policies. Editors have highlighted the following attributes while ensuring the content’s credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
by Monash University
Characterized by pathological weight loss driven by restrictive feeding and excessive exercise behaviors, anorexia nervosa (AN) has one of the highest mortality rates of any psychiatric disease.
Some small clinical trials have shown that psilocybin, the active ingredient in magic mushrooms, may be a potential treatment for anorexia nervosa. The condition is characterized by cognitive inflexibility, or rigid thinking and there is evidence that psilocybin acts to increase this flexibility.
However—crucial to the use of the drug as a recognized treatment for anorexia—is the need to understand how psilocybin actually works in the brain. Now, a study led by Dr. Claire Foldi from the Monash University Biomedicine Discovery Institute and published in the journal Molecular Psychiatry, has studied psilocybin in an animal model of anorexia nervosa—revealing that it improves body weight maintenance in female rats and facilitates cognitive flexibility.
Importantly, the Monash researchers found a specific mechanism within the brain by which psilocybin works to make “anorexic thinking” more pliable, opening the way for targeted therapies.
According to Dr. Foldi, while selective serotonin reuptake inhibitors (antidepressants) are the leading pharmacological treatment, they are used off-label and “they do not improve clinical symptoms in underweight individuals with anorexia,” she said.
“Cognitive inflexibility is a hallmark of the condition often arising before symptoms of anorexia nervosa are obvious, and persisting after weight recovery—making this symptom a primary target for therapeutic intervention.”
More information: K. Conn et al, Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms, Molecular Psychiatry (2024). DOI: 10.1038/s41380-024-02575-9
Explore further
Facebook
Twitter
Email
Feedback to editors
2 hours ago
0
23 hours ago
0
May 12, 2024
0
May 11, 2024
0
May 9, 2024
0
2 hours ago
4 hours ago
4 hours ago
12 hours ago
15 hours ago
16 hours ago
16 hours ago
16 hours ago
16 hours ago
17 hours ago
Jul 26, 2023
Mar 28, 2023
May 1, 2024
Nov 28, 2023
Jan 4, 2024
Apr 23, 2024
2 hours ago
4 hours ago
23 hours ago
23 hours ago
20 hours ago
23 hours ago
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.
Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
We keep our content available to everyone. Consider supporting Science X’s mission by getting a premium account.
Daily science news on research developments and the latest scientific innovations
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web